florquinitau F-18
Sponsors
Bristol-Myers Squibb Services Unlimited Company, Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
Conditions
Early Alzheimer’s Diseasecognitive impairment
Phase 2
Longitudinal multicenter head-to-head harmonization of tau PET tracers (HEAD Study)
RecruitingCTIS2023-510508-31-01
Start: 2024-07-01Target: 150Updated: 2024-12-03
A Randomized, Double-blind, Placebo-controlled, Global Proof-of-concept Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer’s Disease (TargetTau-1)
Active, not recruitingCTIS2023-504840-32-00
Start: 2024-11-08Target: 42Updated: 2025-10-13